Skip to main content
OpenTrials
Completed

NCT Number: NCT05988593

Testing the Cognitive Facilitation Effect by Dietary Supplementation of MelaGene+ Drink

To assess the efficacy of MelaGene+ on cognitive performance

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cognitive Change

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

China Medical University

Taichung, Taiwan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 20 to 65-year-old males or females

Exclusion criteria

  • Participants are breastfeeding, pregnant or planning to become pregnant during the test (self-report)
  • Participants with heart, liver, kidney, endocrine and other major organic diseases (self-reported)
  • Participants take drugs for a long time (self-report)
  • Participants with mental illness or have undergone brain surgery
  • Participants still can not clearly see words with 12pt on computer after corrected vision

Treatment and study plan

Placebo

Dietary Supplement

consume one bottle (30 mL) per day

MelaGene+

Dietary Supplement

consume one bottle (30 mL) per day

Other names: Melaleuca-MelaGene+

Primary outcomes

  1. The change of Match to sample test

    Time frame: Change from Baseline match to sample test value at 8 weeks

    The number of memorized cards was utilized to measure Match to sample test value.

  2. The change of Trail making test

    Time frame: Change from Baseline Trail making test value at 8 weeks

    The time of finishing actions was utilized to measure Trail making test value.

  3. The change of Processing speed test

    Time frame: Change from Baseline Processing speed test value at 8 weeks

    The number of pressing buttons was utilized to measure Processing speed test value.

  4. The change of Mnemonic Similarity Task

    Time frame: Change from Baseline Mnemonic Similarity Task value at 8 weeks

    The proportion of correction about ability on memorizing old things was utilized to measure Mnemonic Similarity Task value.

  5. The change of facial expression cuing task

    Time frame: Change from Baseline facial expression cuing task value at 8 weeks

    The correction of evaluation on facial emotion was utilized to measure facial expression cuing task value.

  6. The change of State-trait anxiety inventory

    Time frame: Change from Baseline State-trait anxiety inventory value at 8 weeks

    The scores of anxiety state was utilized to measure State-trait anxiety inventory value.

  7. The change of score of fatigue

    Time frame: Change from Baseline PSS (The Perceived Stress Scale)-14 value at 8 weeks

    The PSS (The Perceived Stress Scale)-14 questionnaire was utilized to measure fatigue condition.

  8. The change of score of life quality

    Time frame: Change from Baseline WHOQOL-BREF (The World Health Organization Quality of Life Brief Version) value at 8 weeks

    The WHOQOL-BREF (The World Health Organization Quality of Life Brief Version) questionnaire was utilized to measure life quality.

Sponsors and collaborators

Lead sponsor

TCI Co., Ltd.

Industry

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Aug 14, 2023
Registry last updated
Aug 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.